NCT03564548 2021-07-28
REBORN
Tetra Bio-Pharma
Phase 2 Unknown
Clinical Trials
5 trialsNCT00505414 2019-11-01
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Terminated
NCT01675622 2018-05-21
Immediate-Release Oxycodone Capsules Study in Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT00446069 2016-08-29
A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients
Egalet Ltd
Phase 2 Completed
NCT01309386 2013-03-13
A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants
Janssen Pharmaceutical K.K.
Phase 3 Completed